Dashboard
Manage Tickers

TWST


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

twist-bioscience-announces-the-expansion-of-its-dna-synthesis-offering-with-the-launch-of-gene-fragments-with-increased-lengths-ranging-from-18kb-to-50kb
Twist Bioscience Announces The Expansion O...
08/08/2024 12:37:09

Industry leading product available through Twist ecommerce platformTwist Gene Fragments now available up to 5.0kb in length wit...

barclays-maintains-overweight-on-twist-bioscience-lowers-price-target-to-55
Barclays Maintains Overweight on Twist Bio...
08/05/2024 23:48:04

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $6...

sotera-health-posts-upbeat-results-joins-thoughtworks-sonic-automotive-and-other-big-stocks-moving-higher-on-monday
Sotera Health Posts Upbeat Results, Joins ...
08/05/2024 15:22:37

jp-morgan-maintains-underweight-on-twist-bioscience-raises-price-target-to-35
JP Morgan Maintains Underweight on Twist B...
08/05/2024 14:52:48

JP Morgan analyst Tycho Peterson maintains Twist Bioscience (NASDAQ:TWST) with a Underweight and raises the price target fro...

evaluating-twist-bioscience-insights-from-5-financial-analysts
Evaluating Twist Bioscience: Insights From...
08/05/2024 14:00:28

twist-bioscience-and-bitbiome-announced-the-launch-of-a-joint-transaminase-enzyme-screening-kit
Twist Bioscience And bitBiome Announced Th...
08/05/2024 12:04:46

Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthe...

baird-maintains-outperform-on-twist-bioscience-raises-price-target-to-46
Baird Maintains Outperform on Twist Biosci...
08/05/2024 11:14:01

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $...

scorpion-capital-scorpionfund-posts-on-x-we-remain-short-twst-twist-bioscience-with-strong-conviction-that-it-is-a-zero-detailed-thoughts-on-monday-were-doing-a-fresh-intensive-round-of-research-which-we-may-publish-as-a-follow-up-to-our-nov-2022-short-report
Scorpion Capital (@ScorpionFund) Posts On ...
08/02/2024 16:29:27

https://x.com/ScorpionFund/status/1819408275474874573 

twist-bioscience-beats-q3-earnings-forecast-plans-to-achieve-50-gross-margin-by-fiscal-year-2025
Twist Bioscience Beats Q3 Earnings Forecas...
08/02/2024 14:01:13

Twist Bioscience reported a Q3 adjusted EPS loss of $(0.70), surpassing the $(0.77) consensus. With a net loss of $85.6 million...

twist-bioscience-expects-q4-2024-revenues-of-82m-83m-versus-prior-guidance-of-77m-80m-and-consensus-of-79602m
Twist Bioscience Expects Q4 2024 Revenues ...
08/02/2024 11:37:10

For the fourth quarter of fiscal year 2024, Twist provided the following financial guidance:Total revenue of approximately $82 ...

twist-bioscience-expects-2024-revenues-of-310m-311m-versus-prior-guidance-of-300m-304m-and-consensus-of-303906m
Twist Bioscience Expects 2024 Revenues Of ...
08/02/2024 11:35:13

For the full fiscal year 2024, Twist provided the following updated financial guidance:Total revenue is expected to be approxim...

twist-bioscience-q3-2024-adj-eps-070-beats-077-estimate-sales-81464m-beat-77404m-estimate
Twist Bioscience Q3 2024 Adj. EPS $(0.70) ...
08/02/2024 11:32:46

twist-bioscience-announces-clinical-progression-of-pure-biologics-antibody-candidate-discovered-using-twists-antibody-libraries
Twist Bioscience Announces Clinical Progre...
07/18/2024 12:15:45

Pure Biologics' exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumorsTwist Bioscience ...

cathie-wood-touts-palantir-coinbase-and-roku-as-arks-flagship-fund-shifts-focus-from-mag-6-amid-whiff-of-lower-interest-rates
Cathie Wood Touts Palantir, Coinbase And R...
07/11/2024 11:15:15

In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fu...

goldman-sachs-maintains-buy-on-twist-bioscience-raises-price-target-to-55
Goldman Sachs Maintains Buy on Twist Biosc...
07/09/2024 14:47:03

Goldman Sachs analyst Matthew Sykes maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $45...

twist-bioscience-expands-synthetic-viral-controls-portfolio-with-launch-of-synthetic-rna-control-for-h5n1-influenza-a-covers-999-of-hemagglutinin-and-neuraminidase-genome-regions
Twist Bioscience Expands Synthetic Viral C...
07/09/2024 12:11:38

cathie-woods-ark-invest-sells-tesla-shares-worth-145m-amid-rally-driven-by-q2-delivery-numbers-picks-up-palantir-shares-again-today
Cathie Wood's Ark Invest Sells Tesla Share...
07/03/2024 02:26:04

key-takeaways-from-twist-bioscience-analyst-ratings
Key Takeaways From Twist Bioscience Analys...
06/28/2024 17:00:42

barclays-maintains-overweight-on-twist-bioscience-raises-price-target-to-60
Barclays Maintains Overweight on Twist Bio...
06/28/2024 16:02:12

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $4...

td-cowen-maintains-buy-on-twist-bioscience-raises-price-target-to-65
TD Cowen Maintains Buy on Twist Bioscience...
06/13/2024 16:42:11

TD Cowen analyst Steven Mah maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $55 to $65.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION